公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2012 | Phosphorylcholine-containing lipid molecular species profiling in biological tissue using a fast HPLC/QqQ-MS method | Tang C.-H.; PO-NIEN TSAO ; CHING-YU LIN ; Fang L.-S.; Lee S.-H.; Wang W.-H. | Analytical and Bioanalytical Chemistry | 20 | 21 | |
2007 | PPARγ inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats | Lin T.-H.; RONG-SEN YANG ; Tang C.-H.; CHIH-PENG LIN ; WEN-MEI FU | Bone | 57 | 54 | |
2005 | Prostaglandin E2 stimulates fibronectin expression through EP1 receptor, phospholipase C, protein kinase Cα, and c-Src pathway in primary cultured rat osteoblasts | Tang C.-H.; RONG-SEN YANG ; WEN-MEI FU | Journal of Biological Chemistry | 93 | 90 | |
2017 | Protein-energy wasting significantly increases healthcare utilization and costs among patients with chronic kidney disease: a propensity-score matched cohort study | CHIA-TER CHAO ; Tang C.-H.; Cheng R.W.-Y.; Wang M.Y.-H.; KUAN-YU HUNG | Current Medical Research and Opinion | 23 | 20 | |
2018 | Rebuttal comments on “Glucocorticoids in breast cancer treatment: Real benefit or selection bias?” | CHING-HUNG LIN ; Tang C.-H. | Breast Cancer Research and Treatment | 0 | 0 | |
2005 | Regulation by ultrasound treatment on the integrin expression and differentiation of osteoblasts | RONG-SEN YANG ; Win-Li Lin ; Chen Y.-Z.; Tang C.-H.; Huang T.-H.; Lu B.-Y.; WEN-MEI FU | Bone | 125 | 109 | |
2002 | Regulation of fibronectin fibrillogenesis by protein kinases in cultured rat osteoblasts | RONG-SEN YANG ; Tang C.-H.; Ling Q.-D.; SHING-HWA LIU ; WEN-MEI FU | Molecular Pharmacology | 20 | 19 | |
2008 | Regulation of the maturation of osteoblasts and osteoclastogenesis by glutamate | Lin T.-H.; RONG-SEN YANG ; Tang C.-H.; Wu M.-Y.; WEN-MEI FU | European Journal of Pharmacology | 42 | 43 | |
2003 | Relationships between length of stay and hospital characteristics under the case-payment system in Taiwan: Using data for vaginal delivery patients | Lin H.-C.; YU-CHI TUNG ; Chen C.-C.; Tang C.-H. | Chang Gung Medical Journal | 7 | 0 | |
2005 | Rhodostomin inhibits thrombin-enhanced adhesion of ROS 17/2.8 cells through the blockade of alphav beta 3 integrin | RONG-SEN YANG ; Chiang H.-S.; Tang C.-H.; Yeh C.-S.; TUR-FU HUANG | Toxicon | 10 | 10 | |
2011 | Ribosome inactivating protein B-chain induces osteoclast differentiation from monocyte/macrophage lineage precursor cells | Wang Y.-M.; Lu T.-L.; PING-NING HSU ; Tang C.-H.; Chen J.-H.; Liu K.-C.; Kao J.-T.; Tzen J.T.C.; Wu Y.-Y. | Bone | 9 | 9 | |
2009 | SDF-1alpha up-regulates interleukin-6 through CXCR4, PI3K/Akt, ERK, and NF-kappaB-dependent pathway in microglia | Lu D.-Y.; Tang C.-H.; Yeh W.-L.; Wong K.-L.; CHIH-PENG LIN ; Chen Y.-H.; Lai C.-H.; Chen Y.-F.; Leung Y.-M.; WEN-MEI FU | European Journal of Pharmacology | 108 | 105 | |
2009 | Stromal cell-derived factor-1 increase αvβ3 integrin expression and invasion in human chondrosarcoma cells | Lai T.-H.; Fong Y.-C.; WEN-MEI FU ; RONG-SEN YANG ; Tang C.-H. | Journal of Cellular Physiology | 40 | 36 | |
2007 | Stromal cell-derived factor-1 induces matrix metalloprotease-13 expression in human chondrocytes | Chiu Y.-C.; RONG-SEN YANG ; Hsieh K.-H.; Fong Y.-C.; Way T.-D.; Lee T.-S.; Wu H.-C.; WEN-MEI FU ; Tang C.-H. | Molecular Pharmacology | 78 | 78 | |
2018 | Survival benefit of patients with early-stage ovarian carcinoma treated with paclitaxel chemotherapeutic regimens | Chen C.-A.; CHUN-JU CHIANG ; Chen Y.-Y.; You S.-L.; Hsieh S.-F.; Tang C.-H.; WEN-FANG CHENG | Journal of Gynecologic Oncology | 2 | 2 | |
2008 | Thrombin-induced IL-6 production in human synovial fibroblasts is mediated by PAR1, phospholipase C, protein kinase Cα, c-Src, NF-kappaB and p300 pathway | Chiu Y.-C.; Fong Y.-C.; Lai C.-H.; Hung C.-H.; Hsu H.-C.; Lee T.-S.; RONG-SEN YANG ; WEN-MEI FU ; Tang C.-H. | Molecular Immunology | 50 | 50 | |
2011 | TNF-α increases αvβ3 integrin expression and migration in human chondrosarcoma cells | CHUN-HAN HOU ; RONG-SEN YANG ; Hou S.-M.; Tang C.-H. | Journal of Cellular Physiology | 24 | 22 | |
2019 | Tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis: a cost-effectiveness analysis compared with adalimumab in Taiwan | Chen D.-Y.; PING-NING HSU ; Tang C.-H.; Claxton L.; Valluri S.; Gerber R.A. | Journal of Medical Economics | 10 | 8 | |
2020 | Treatment evolution and improved survival in multiple myeloma in Taiwan | Tang C.-H.; HSIN-AN HOU ; KUAN-CHIH HUANG ; Qiu H.; Liu Y. | Annals of Hematology | 10 | | |
2021 | Treatment pathways and disease journeys differ before and after introduction of novel agents in newly diagnosed multiple myeloma in Taiwan | Liu Y.; Tang C.-H.; Qiu H.; Siggins S.; HSIN-AN HOU | Scientific Reports | 4 | 2 | |